Susan M. Efler

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

Arthur Μ. Krieg, Tong Wu, Risini D. Weeratna et al. · Proceedings of the National Academy of Sciences · 1998 · 399 citations · Full text

Stimulatory Cpg Motifs, Immunology, Molecular Biology +16

CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

Curtis Cooper, Heather L. Davis, Mary L. Morris et al. · Journal of Clinical Immunology · 2004 · 328 citations

Vaccination, Vaccine Development, Engerix-b� Hbv Vaccine +6

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

Curtis Cooper, Heather L. Davis, Mary L. Morris et al. · Vaccine · 2004 · 245 citations

Vaccination, Vaccine Safety, Cross-protection +9

Induction of Systemic TH1-Like Innate Immunity in Normal Volunteers Following Subcutaneous but Not Intravenous Administration of CPG 7909, a Synthetic B-Class CpG Oligodeoxynucleotide TLR9 Agonist

Arthur Μ. Krieg, Susan M. Efler, Michael Wittpoth et al. · Journal of Immunotherapy · 2004 · 183 citations

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus

John G. McHutchison, Bruce R. Bacon, Stuart C. Gordon et al. · Hepatology · 2007 · 112 citations · Full text

Immunodeficiencies, Viral Immunity, Immunology +17